FIELD: medicine.
SUBSTANCE: interferon is measured in plasmocytoid dendrite cells at week 12 of the treatment. Its gain in adults and children twenty times as much as compared to the pre-treatment initial level, or 2.6×102 times as much in adults, and 1.2×102 as much as compared to the normal values, the stable positive antiviral treatment response is predicted.
EFFECT: method enables providing the more accurate prediction for selecting the optimum therapeutic approach in each patient.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF ANTIVIRAL THERAPY IN CHRONIC HEPATITIS C IN ADULTS AND CHILDREN | 2014 |
|
RU2589283C2 |
| METHOD OF TREATING CHRONIC VIRAL HEPATITIS C | 2011 |
|
RU2459629C1 |
| METHOD FOR PREDICTING THE ABSENCE OF REGRESS OF HEPATIC FIBROSIS IN THE PATIENTS WITH CHRONIC HEPATITIS C | 2019 |
|
RU2723387C1 |
| METHOD FOR PREDICTION OF ANTIVIRAL THERAPY (AVT) EFFICACY IN CHRONIC HEPATITIS B (CHB) | 2011 |
|
RU2454666C1 |
| METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL TREATMENT OF CHRONIC VIRAL HEPATITIS C | 2013 |
|
RU2546032C2 |
| METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
| METHOD FOR PREDICTION OF EFFICACY OF ANTIVIRAL THERAPY IN ADULT PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1b | 2012 |
|
RU2522500C1 |
| DIAGNOSTIC TECHNIQUE FOR HEPATIC CIRRHOSIS (STAGE F4) IN THE OUTCOME OF CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2724595C1 |
| METHOD FOR PREDICTING OF STABLE REMISSION AT CARRYING OUT OF ANTIVIRAL THERAPY AT SICK OF ACUTE HEPATITIS C | 2007 |
|
RU2339949C1 |
| METHOD OF TREATING VIRAL HEPATITIS C | 2012 |
|
RU2496512C1 |
